Informa
TIDES Asia: Oligonucleotide & Peptide Therapeutics
2026年2月24-26日
日本, 東京, Grand Nikko Tokyo Daiba

主要會議第2天

主要會議第2天
7:45am - 8:10am25 分
Main Conference
主要會議
Registration and Coffee
報到與咖啡時光
    8:10am - 8:15am5 分
    Main Conference
    主要會議
    Chairperson’s Remarks
    議長致辭
      8:15am - 8:45am30 分
      Main Conference
      主要會議
      Learn How Electrostatic Drying Technology Can Help
      了解靜電乾燥技術的優勢
      • Keith Cronce - Chief Operating Officer, Fluid Air, A Division of Spraying Systems
      Concurrent Tracks
      8:45am - 9:15am30 分
      Oligonucleotide CMC
      寡核苷酸CMC
      Characterization of Partially Phosphorothiolated Oligonucleotides: Analytical Strategies for CMC Support
      • Leo Joyce, PhD - Director, Analytical Department, Arrowhead Pharmaceuticals
      8:45am - 9:15am30 分
      mRNA Advances Track
      mRNA進步分會
      Chemical Synthesis of mRNAs Based on Efficient Capping Reaction
      基於高效加帽反應的mRNA化學合成
      • Hiroshi Abe, PhD - Professor, Department of Chemistry, Graduate School, Nagoya University
      9:15am - 9:45am30 分
      Oligonucleotide CMC
      寡核苷酸CMC
      A Deep Dive into Detritylation Making it Safer and Sustainable
      • Yogesh Sanghvi, PhD - President, Rasayan Inc.
      9:15am - 9:45am30 分
      mRNA Advances Track
      mRNA進步分會
      Advancing Oligonucleotide and mRNA Therapeutics: TUG1 ASO for Recurrent Glioblastoma and Runx1 mRNA for Knee Osteoarthritis
      寡核苷酸・mRNA醫藥進歩：治療復發性膠質母細胞瘤的TUG1 ASO和治療膝骨關節炎的Runx1 mRNA
      • Shiro Akinaga, PhD - President and CEO, NANO MRNA, Co., Ltd.
      9:45am - 10:15am30 分
      Oligonucleotide CMC
      寡核苷酸CMC
      Redefining standards: empowering sustainable synthesis
        9:45am - 10:15am30 分
        mRNA Advances Track
        mRNA進步分會
        Advances in mRNA-based Therapeutics for Protein Replacement
        基於mRNA蛋白質替代療法的進步
        • Pad Chivukula, PhD - Chief Scientific Officer and COO, Arcturus Therapeutics
        10:15am - 10:55am40 分
        Networking Refreshment Break with Poster and Exhibit Viewing
        社交茶歇 （包含參觀海報/展覽）
        Networking Refreshment Break with Poster and Exhibit Viewing
        社交茶歇 （包含參觀海報/展覽）
          10:20am - 10:35am15 分
          TIDES Talks in the Exhibit Hall
          展廳的TIDES演講
          Navigating the Next Phase: Real-World Lessons in Oligo Development
          • Alun Garner - Business Development Manager, Nucleic Acid Solutions Division, Agilent Technologies
          Concurrent Conference Tracks
          同時舉行的會議分會
          10:55am - 11:00am5 分
          Oligonucleotide Track
          寡核苷酸分會
          Chairperson’s Remarks: Track 1
          議長致辭：分會1
            10:55am - 11:00am5 分
            Peptide Track
            胜肽分會
            Chairperson’s Remarks: Track 2
            議長致辭：分會2
              11:00am - 11:30am30 分
              Oligonucleotide Track
              寡核苷酸分會
              Formulation Innovations for Future Oligonucleotide Therapies: Insights Inspired by Biologics
              未來寡核苷酸療法上的配方創新：受生物製劑啟發的見解
              • Tomoya Takenaka, PhD - Principal Scientist, Drug Product and Device Development, Takeda Pharmaceutical Company
              11:00am - 11:30am30 分
              Peptide Track
              胜肽分會
              De Novo Discovery of Potent Peptidomimetics by Diverse Genetic Code Reprogramming
              通過多種遺傳密碼重編程重新發現有效的肽模擬物
              • Maxwell Sigal - Ph.D. Candidate, Lab of Prof. Hiroaki Suga, The University of Tokyo
              11:30am - 12:00pm30 分
              Oligonucleotide Track
              寡核苷酸分會
              Insights into siRNA Duplex Stability and Formulation Screening by UV-Vis and Rapid-screening DSC Thermal Analyses
              透過紫外可見光和快速篩選 DSC 熱分析深入了解 siRNA 雙鏈體穩定性和配方篩選
              • Molly Blevins, PhD - Principal Scientist, Genentech
              11:30am - 12:00pm30 分
              Peptide Track
              胜肽分會
              R2R01: A Potent RXFP1 Peptide Agonist in Phase 2 Clinical Development for Cardiorenal Conditions
              • Federica Tucci - Principal Research Scientist, IRBM
              12:00pm - 12:30pm30 分
              Oligonucleotide Track
              寡核苷酸分會
              Achieving Quality and Regulatory Confidence in Oligo Therapeutics with Advanced Purification
              透過先進純化技術實現寡核苷酸醫藥品質和監管信心
              • Alun Garner - Business Development Manager, Nucleic Acid Solutions Division, Agilent Technologies
              12:00pm - 12:30pm30 分
              Peptide Track
              胜肽分會
              Late Breaking Presentation
              最新簡報
                12:30pm - 1:40pm70 分
                Oligonucleotide Track
                寡核苷酸分會
                Networking Luncheon with Poster and Exhibit Viewing
                交流午餐會 （包含參觀海報/展覽）
                  12:30pm - 1:40pm70 分
                  Peptide Track
                  胜肽分會
                  Networking Luncheon with Poster and Exhibit Viewing
                  交流午餐會 （包含參觀海報/展覽）
                    Concurrent Tracks
                    1:40pm - 1:45pm5 分
                    Oligonucleotide Track
                    寡核苷酸分會
                    Chairperson’s Remarks: Track 1
                    議長致辭：分會1
                      1:40pm - 1:45pm5 分
                      Peptide Track
                      胜肽分會
                      Chairperson’s Remarks: Track 2
                      議長致辭：分會2
                      • Ved Srivastava, PhD - CTO, Perpetual Medicines
                      1:45pm - 2:15pm30 分
                      Oligonucleotide Track
                      寡核苷酸分會
                      Understanding UF/DF Capabilities for Enhancing ASO Processing to Make a Liquid or Lyo API
                      了解超濾/去膜功能在液態或冷凍乾燥API生產中增強反式氧化製程 (ASO) 的作用
                      • Robert Gronke, PhD - Senior Principal Scientist, Biogen, Inc
                      1:45pm - 2:15pm30 分
                      Peptide Track
                      胜肽分會
                      Switching off Transcription Factors Using Intracellular Library-derived Peptides
                      利用胞內文庫衍生胜肽關閉轉錄因子
                      • Jody Mason, PhD - Professor of Biochemistry, University of Bath
                      2:15pm - 2:45pm30 分
                      Oligonucleotide Track
                      寡核苷酸分會
                      Oligo CMC Presentation
                      OligoCMC簡報
                        2:15pm - 2:45pm30 分
                        Peptide Track
                        胜肽分會
                        Mixed-Chirality Prohibitin Peptides Enhance Stability and In Vivo Effects on Obesity
                        透過混合手性抑制胜肽提高穩定性並增強體內抗肥胖功效
                        • David Craik, PhD - Professor of Biomolecular Structure, University of Queensland
                        2:45pm - 3:15pm30 分
                        Oligonucleotide Track
                        寡核苷酸分會
                        Challenges of Raw Material Acquisition for Oligonucleotide Synthesis
                        寡核苷酸合成上原料採購的課題
                        • Long Ma, PhD - CEO and Chief Scientist, Orilife Biotech
                        2:45pm - 3:15pm30 分
                        Peptide Track
                        胜肽分會
                        Selection of Constrained Peptides as Functional Modulators of CB2R and Characterization of Functional Effects in IBD Models
                        作為CB2R功能調節劑的約束肽之選擇與IBD模型中功能效應的表徵
                        • David O'Connell, PhD - Professor, School of Biomolecular & Biomedical Science, University College Dublin
                        3:15pm - 3:45pm30 分
                        Oligonucleotide Track
                        寡核苷酸分會
                        Networking Refreshment Break with Poster and Exhibit Viewing
                        社交茶歇 （包含參觀海報/展覽）
                          3:15pm - 3:45pm30 分
                          Peptide Track
                          胜肽分會
                          Networking Refreshment Break with Poster and Exhibit Viewing
                          社交茶歇 （包含參觀海報/展覽）
                            Concurrent Tracks
                            3:45pm - 4:15pm30 分
                            Oligonucleotide Track
                            寡核苷酸分會
                            Development and Manufacture of Oligonucleotides via Enzymatic Ligation
                            透過酵素連接技術開發和生產寡核苷酸
                            • Scott May, PhD - VP of Chemistry, Synthetic Molecule Design & Development, Eli Lilly and Company
                            • Arne Berthelmann - Senior Director Oligonucleotide R&D, Bachem AG
                            3:45pm - 4:15pm30 分
                            Peptide Track
                            胜肽分會
                            Applying PeptiDream’s Peptide Discovery Platform System (PDPS) to Identify and Optimize Oral IL-17 Peptide Inhibitors for Psoriasis
                            透過PeptiDream的藥物發現和開發平台（PDPS）可識別和優化用於治療乾癬的口服 IL-17 胜肽抑制劑
                            • Haruaki Kurasaki, PhD - Director, Medicinal Chemistry, PeptiDream
                            4:15pm - 4:45pm30 分
                            Oligonucleotide Track
                            寡核苷酸分會
                            Technology and Innovation in Oligonucleotide CMC
                            寡核苷酸CMC上的技術與創新
                            • Masafumi Iwamoto, PhD - Associate Director of Technology and Innovation, Nitto Denko Avecia
                            4:15pm - 4:45pm30 分
                            Peptide Track
                            胜肽分會
                            Harnessing Venom for Drug Discovery: Developing a High-Performance Venom Library Platform with a Machine Learning-Enabled Rapid Hit-to-Lead Workflow
                            活用Venom進行藥物發現：利用ML支援的快速先導化合物製程，開發高性能Venom庫平台
                            • Yingnan Zhang, PhD - Senior Principal Scientific Manager, Genentech
                            4:45pm - 5:15pm30 分
                            Oligonucleotide Track
                            寡核苷酸分會
                            Lessons Learned Building an Oligo CMC Program for a Small Company: Doing More with Less
                            為小型企業建立寡核苷酸 CMC 計劃的經驗教訓：事半功倍
                            • Pablo Lores Lareo, PhD - CMC Director, Sylentis
                            4:45pm - 5:15pm30 分
                            Peptide Track
                            胜肽分會
                            Antibody Peptide Conjugates: The Next Big Modality?
                            APC：一種有前景的模式？
                            • Kerry Blanchard, MD, PhD - CEO, Chairman and Founder, Perpetual Medicines
                            5:15pm - 6:15pm60 分
                            Oligonucleotide Track
                            寡核苷酸分會
                            Networking Cocktail Reception with Poster and Exhibit Viewing
                            社交雞尾酒會 （包含參觀海報/展覽）
                              5:15pm - 6:15pm60 分
                              Peptide Track
                              胜肽分會
                              Networking Cocktail Reception with Poster and Exhibit Viewing
                              社交雞尾酒會 （包含參觀海報/展覽）
                                6:15pm - 6:20pm5 分
                                Oligonucleotide Track
                                寡核苷酸分會
                                Close of Day Two
                                第2天結束
                                  6:15pm - 6:20pm5 分
                                  Peptide Track
                                  胜肽分會
                                  Close of Day Two
                                  第2天結束

                                    * 活動內容有可能不事先告知作更動及調整。

                                    會前研討會（上午） & 主要會議第1天（下午）
                                    Next 主要會議第3天